Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6116966 | Immunology Letters | 2016 | 8 Pages |
Abstract
IL-12p40 homodimer, a natural antagonist of IL-12 and IL-23, performs an important role in the expression of proinflammatory cytokines that is essential for Th1 and Th17 immune responses. Here, we reveal the therapeutic and immunosuppressive effect of the IL-12p40 subunit ((p40)2-Fc) in an experimental autoimmune arthritis model. We hypothesized that (p40)2-Fc may reduce the inflammatory response and the activation of T cells. In this study, we intraperitoneally injected (p40)2-Fc into collagen induced arthritis (CIA) mice to identify whether (p40)2-Fc attenuates CIA severity. (p40)2-Fc reduced the development of CIA, joint inflammation and cartilage destruction. (p40)2-Fc also significantly decreased the concentration of serum immunoglobulin as well as the number of T cells and C II specific T cells. In addition, osteoclastogenesis in (p40)2-Fc treated mice was down-regulated compared to the mice treated with (p40)2-Fc control. We observed that (p40)2-Fc treatment alleviates arthritis in mice with CIA, reducing inflammation and osteoclast differentiation. These findings suggest that (p40)2-Fc can be a potential therapeutic approach for autoimmune arthritis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Seon-Yeong Lee, Seung Hoon Lee, Seong-Jeong Park, Doo-Jin Kim, Eun-Kyung Kim, Jae-Kyung Kim, Se-Hwan Yang, Sung-Hwan Park, Young-Chul Sung, Ho-Youn Kim, Mi-La Cho,